Apply to trial NCT07365904

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 2Drug trial

Investigating Ovulation Inhibition for Use as a Contraceptive

A single-centre, open-label, randomised, phase II study on the maintenance of ovulation inhibition after intentional application errors during 84 days of treatment with MR 130A 01 contraceptive transdermal patch

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Investigating Ovulation Inhibition for Use as a Contraceptive

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening